UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 639

Sortiert nach

A test method for measuring chloride diffusion coefficients through nonsaturated concrete: Part I. The instantaneous plane source diffusion case

Cement and concrete research, 2002-07, Vol.32 (7), p.1113-1123

2002

Volltextzugriff (PDF)

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine

Cancer, 2002-08, Vol.95 (4), p.751-757

2002

Volltextzugriff (PDF)

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer

Critical reviews in oncology/hematology, 2012-09, Vol.83 (3), p.341-352

2012

Volltextzugriff (PDF)

36th annual San Antonio Breast Cancer Symposium. Resumen de lo más destacado

Revista de senología y patología mamaria, 2014-04, Vol.27 (2), p.87-93

2014

Volltextzugriff (PDF)

First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study

Cancer research communications, 2024-06, Vol.4 (6), p.1609-1619

2024

Volltextzugriff (PDF)

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

The New England journal of medicine, 2018-07, Vol.379 (2), p.122-137

2018

Volltextzugriff (PDF)

Generalization of the possibility of eliminating the filtration step in the determination of acid-soluble chloride content in cement and concrete by potentiometric titration

Cement and concrete research, 2004-12, Vol.34 (12), p.2291-2295

2004

Volltextzugriff (PDF)

Measurements of Chloride Activity Coefficients in Real Portland Cement Paste Pore Solutions

Journal of the American Ceramic Society, 2001-12, Vol.84 (12), p.3008-3012

2001

Volltextzugriff (PDF)

A phase I-II study to evaluate safety and efficacy of the combination of niraparib plus cabozantinib in patients with advanced kidney/urothelial carcinoma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS4593-TPS4593

2018

Volltextzugriff (PDF)

A correlative biomarker study and integrative prognostic model in chemotherapy‐naïve metastatic castration‐resistant prostate cancer treated with enzalutamide

The Prostate, 2023-03, Vol.83 (4), p.376-384

2023

Volltextzugriff (PDF)

PD38-02 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA: LONG-TERM OUTCOMES FROM JAVELIN BLADDER 100 IN SUBGROUPS DEFINED BY FIRST-LINE CHEMOTHERAPY REGIMEN AND ANALYSIS OF OVERALL SURVIVAL FROM START OF FIRST-LINE CHEMOTHERAPY

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

Phase II randomized study of first line avelumab with carboplatin-gemcitabine versus carboplatin-gemcitabine alone in patients with metastatic urothelial carcinoma ineligible for cisplatin-based therapy

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS4591-TPS4591

2018

Volltextzugriff (PDF)

Pembrolizumab (pembro) versus investigator’s choice (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (UC): 2-year follow-up from the phase 3 KEYNOTE-045 trial

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.4521-4521

2018

Volltextzugriff (PDF)

Comprehensive molecular and immunohistochemical analysis of advanced renal cell carcinoma patients treated with mTOR inhibitors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.4559-4559

2018

Volltextzugriff (PDF)

Phase II trial of afatinib in patients with advanced/metastatic urothelial carcinoma (UC) with genetic alterations in ERBB receptors 1-3 who failed on platinum-based chemotherapy (CT)

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.TPS540-TPS540

2018

Volltextzugriff (PDF)

SPAZO2 (SOGUG): Outcomes of patients treated with pazopanib as first line in mRC according to gender in real world

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.623-623

2018

Volltextzugriff (PDF)

Two-year follow-up from the phase 3 KEYNOTE-045 trial of pembrolizumab (pembro) vs investigator’s choice (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (UC)

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.410-410

2018

Volltextzugriff (PDF)

A test method for measuring chloride diffusion coefficients through nonsaturated concrete

Cement and concrete research, 2002-07, Vol.32 (7), p.1113-1123

2002

Volltextzugriff (PDF)

Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study

Clinical genitourinary cancer, 2022-02, Vol.20 (1), p.25-34

2022

Volltextzugriff (PDF)

First-line lenvatinib + pembrolizumab treatment across non-clear cell renal cell carcinomas: Results of the phase 2 KEYNOTE-B61 study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4518-4518

2023

Volltextzugriff (PDF)

PD55-01 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA IN THE JAVELIN BLADDER 100 TRIAL: SUBGROUP ANALYSIS BY DURATION OF TREATMENT-FREE INTERVAL FROM END OF CHEMOTHERAPY TO START OF MAINTENANCE

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Volltextzugriff (PDF)

Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC) in the JAVELIN Bladder 100 trial: Subgroup analysis by duration of treatment-free interval (TFI) from end of chemotherapy to start of maintenance

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4527-4527

2021

Volltextzugriff (PDF)

Proof by UV-visible modulated reflectance spectroscopy of the breakdown by carbonation of the passivating layer on iron in alkaline solution

Surface science, 1995-06, Vol.330 (1), p.L651-L656

1995

Volltextzugriff (PDF)

Abstract S3-08: Randomized comparison of adjuvant tamoxifen (T) plus ovarian function suppression (OFS) versus tamoxifen in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC): Analysis of the SOFT trial

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.S3-S3-08

2015

Volltextzugriff (PDF)

26 – 50 von 639

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(591)
Mit Volltextzugriff
(613)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

A test method for measuring chloride diffusion coefficients through nonsaturated concrete: Part I. The instantaneous plane source diffusion case

Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre study

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer

36th annual San Antonio Breast Cancer Symposium. Resumen de lo más destacado

First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

Generalization of the possibility of eliminating the filtration step in the determination of acid-soluble chloride content in cement and concrete by potentiometric titration

Measurements of Chloride Activity Coefficients in Real Portland Cement Paste Pore Solutions

A phase I-II study to evaluate safety and efficacy of the combination of niraparib plus cabozantinib in patients with advanced kidney/urothelial carcinoma

A correlative biomarker study and integrative prognostic model in chemotherapy‐naïve metastatic castration‐resistant prostate cancer treated with enzalutamide

PD38-02 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA: LONG-TERM OUTCOMES FROM JAVELIN BLADDER 100 IN SUBGROUPS DEFINED BY FIRST-LINE CHEMOTHERAPY REGIMEN AND ANALYSIS OF OVERALL SURVIVAL FROM START OF FIRST-LINE CHEMOTHERAPY

Phase II randomized study of first line avelumab with carboplatin-gemcitabine versus carboplatin-gemcitabine alone in patients with metastatic urothelial carcinoma ineligible for cisplatin-based therapy

Pembrolizumab (pembro) versus investigator’s choice (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (UC): 2-year follow-up from the phase 3 KEYNOTE-045 trial

Comprehensive molecular and immunohistochemical analysis of advanced renal cell carcinoma patients treated with mTOR inhibitors

Phase II trial of afatinib in patients with advanced/metastatic urothelial carcinoma (UC) with genetic alterations in ERBB receptors 1-3 who failed on platinum-based chemotherapy (CT)

SPAZO2 (SOGUG): Outcomes of patients treated with pazopanib as first line in mRC according to gender in real world

Two-year follow-up from the phase 3 KEYNOTE-045 trial of pembrolizumab (pembro) vs investigator’s choice (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (UC)

A test method for measuring chloride diffusion coefficients through nonsaturated concrete

Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study

First-line lenvatinib + pembrolizumab treatment across non-clear cell renal cell carcinomas: Results of the phase 2 KEYNOTE-B61 study

PD55-01 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA IN THE JAVELIN BLADDER 100 TRIAL: SUBGROUP ANALYSIS BY DURATION OF TREATMENT-FREE INTERVAL FROM END OF CHEMOTHERAPY TO START OF MAINTENANCE

Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC) in the JAVELIN Bladder 100 trial: Subgroup analysis by duration of treatment-free interval (TFI) from end of chemotherapy to start of maintenance

Proof by UV-visible modulated reflectance spectroscopy of the breakdown by carbonation of the passivating layer on iron in alkaline solution

Abstract S3-08: Randomized comparison of adjuvant tamoxifen (T) plus ovarian function suppression (OFS) versus tamoxifen in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC): Analysis of the SOFT trial

Suchergebnisse filtern